Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosisStephen L. Pinkosky(Esperion Therapeutics (United States)), Narendra D. Lalwani(Esperion Therapeutics (United States))Nature CommunicationsNovember 28, 201610.1038/ncomms13457Cited by 475SaveCiteExport RISWatch citationsRelated PapersAMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism|Journal of Lipid Research|2012|234